To truly understand the future of metabolic therapy, we need to look beyond GLP-1toward GIP , amylin , and glucagon and how they work together in multi-hormonal harmony
What else your prescriber may ask about Alongside break length, previous dose, tolerance and reason for stopping, a thorough restart assessment may also cover: Any personal or family history of medullary thyroid carcinoma or MEN2 syndrome, which are contraindications to tirzepatide Any new medicines started during your break, including other diabetes treatments, oral contraceptives or medicines with a narrow therapeutic index Whether youve lost less than 5% of your initial body weight after 6 months at your highest tolerated dose in the past NICE guidance advises reviewing whether continued treatment remains appropriate in this situation Any planned surgery, anaesthesia or upcoming medical procedures What to verify before restarting with any provider Unregulated and counterfeit weight-loss medicines are a recognised patient-safety risk
Important: Do not take two 7mg tablets to reach the 14mg dose
J., Segal, A
Heres how the STAT story started: Eli Lillys next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, but rates of side effects were high and many participants discontinued the treatment, including people who felt they were losing too much weight
Its crucial to discuss the procedure with a healthcare provider beforehand, disclose any medical conditions or medications, and follow their guidance for dosage and frequency to ensure safety and minimize risks
